Laser Treatment for Vulvar Lichen Sclerosus
Effectiveness of Ablative Fractional 2940 nm Laser Treatment for Vulvar Lichen Sclerosus
Sponsor: Beth Israel Deaconess Medical Center
Terminated
Recruitment was significantly impacted by the COVID-19 pandemic.
Other terminated trials from Beth Israel Deaconess Medical Center
- Diagnoses Disease · Phase NA · Jun 2025
- Blood Pressure · Jun 2025
- Hidradenitis Suppurativa · Phase PHASE2 · Apr 2025
- Cesarean Section Complications · Phase NA · Feb 2025
- Migraine Headache · Phase NA · Jan 2025
See all terminations from Beth Israel Deaconess Medical Center
Other Vulvar Lichen Sclerosus trials with similar outcome
Listed as NCT04134494, this NA trial focuses on Vulvar Lichen Sclerosus and remains terminated or withdrawn. Sponsored by Beth Israel Deaconess Medical Center, it has been updated 8 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jul 2022 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Jul 2022 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Feb 2020 — Dec 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Not Yet Recruiting NA
-
Nov 2019 — Dec 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beth Israel Deaconess Medical Center
- Sciton
For direct contact, visit the study record on ClinicalTrials.gov .